Intestinal Diseases clinical trials
The registry lists 260 studies for Intestinal Diseases across more than 10 countries. 53 are recruiting or about to start. 74 of them are mainly about Intestinal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 65 narrower conditions too, such as Colorectal Neoplasms: 18,496 studies, 4,478 open.
Get an email when these change. Save the Intestinal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Exact Sciences Corporation (6) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (5) · Menarini Group (5) · Medtronic - MITG (5) · Pharmbio Korea Co., Ltd. (4) · Bausch Health Americas, Inc. (4) · Washington University School of Medicine (3) · Boston Children's Hospital (3)
What is being tested here
Drugs under test in Intestinal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Glepaglutide | 1 | 2 | 2 |
| Bupivacaine | 1 | 0 | 2 |
| Glutens | 1 | 0 | 1 |
| Peppermint oil | 1 | 0 | 1 |
| Anti-PD-1/Anti-VEGF Bispecific Antibody PF-08634404 | 1 | 1 | 1 |
| Repotrectinib | 1 | 0 | 1 |
| Infliximab | 1 | 1 | 1 |
| SGM-101 | 1 | 0 | 1 |
| Alvimopan | 0 | 3 | 5 |
| Ibodutant | 0 | 3 | 5 |
Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · NSAIDs 3 · Corticosteroids 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury · Phase 3 · Cook MyoSite
- Dec 2026Fortified Oral Rehydration Therapy for Pediatric Diarrhea · Paul A Breslin
- Dec 2026Abdominal Electrical Stimulation for Bowel Dysfunction in SCI · University of Alberta
- Dec 2026Peppermint Oil as a Treatment for Children With Bladder and Bowel Dysfunction · Children's Hospital of Orange County
- Dec 2026Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty · Children's Hospital of Fudan University
- Dec 2026Effect of Acupuncture on Mild to Moderate Active Crohn's Disease · Shanghai Institute of Acupuncture, Moxibustion and Meridian
- Jan 2027Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients · University of California, Los Angeles
- Jan 2027Gut Leakage' in Dengue · University of Oxford
- Mar 2027Effects of Hippotherapy in Children With Cerebral Palsy · Fenerbahce University
- Mar 2027Effects of Hippotherapy in Children With Autism Spectrum Disorder · Fenerbahce University
Who these studies take
Of the 37 Intestinal Diseases studies recruiting now, 17 (46%) set no upper age limit and 16 (43%) stop at 75 or younger. 14 (38%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (16%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 7 (19%) | 7 (19%) |
| 18 | 27 (73%) | 27 (73%) |
| 30 | 29 (78%) | 29 (78%) |
| 40 | 29 (78%) | 29 (78%) |
| 50 | 29 (78%) | 29 (78%) |
| 65 | 28 (76%) | 28 (76%) |
| 75 | 23 (62%) | 23 (62%) |
| 85 | 19 (51%) | 19 (51%) |
Across all 260 studies, recruiting or not: 40% stop at 75 or younger and 25% at 65; 22% take children; 6% are for women only and 1% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Intestinal Diseases studies take
Of 14 phase 2 interventional studies under Intestinal Diseases, half reached primary completion within 27 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 2 | 27 mo14–31 · 14 studies | — | — |
| Interventional, no phase | 21 mo12–56 · 63 studies | — | 23 mo13–43 · 54 studies |
| Observational | 33 mo14–102 · 35 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
- Fermented Foods and Bowel Health in SCIOct 23, 2026NCT07640152
Studies
Recruiting first, then most recently updated. Showing 50 of 260. Browse all 260 → or search them.
- The Effects of Kegel Exercise Combined With Biofeedback Therapy on Bowel Function Recovery, Emotional Distress, and Quality of Life in Patients Following Low Anterior Resection for Rectal CancerEnrolling by invitationNCT07253298Not applicable1 country
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruitingNCT071023681 country
- Fermented Foods and Bowel Health in SCIRecruitingNCT07640152Not applicable1 country
- Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual DysfunctionRecruitingNCT05380856Not applicable1 country
- Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerRecruitingNCT07222800Phase 317 countries
- Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBSRecruitingNCT07197944Phase 314 countries
- Immune Responses to GlutenEnrolling by invitationNCT05209568Not applicable1 country
- Comparison of a New Non-invasive Device With the Invasive Gold-standard Investigation to Assess Function of the Large Bowel in ChildrenNot yet recruitingNCT07789782Not applicable1 country
- Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal ResectionsRecruitingNCT07351071Not applicable1 country
- Understanding New Cachexia Subtypes Through Observational Epidemiological ResearchRecruitingNCT077763531 country
- Gut Leakage' in DengueRecruitingNCT076029201 country
- Effects of Hippotherapy in Children With Cerebral PalsyNot yet recruitingNCT07739680Not applicable1 country
- Effects of Hippotherapy in Children With Autism Spectrum DisorderNot yet recruitingNCT07739693Not applicable1 country
- Outcomes of Outpatients in an Gut Microbiota ClinicRecruitingNCT068455271 country
- Abdominal Electrical Stimulation for Bowel Dysfunction in SCIEnrolling by invitationNCT06948175Not applicable1 country
- Implementation of a Pediatric ERAS-based Protocol in Intestinal Resection With Primary AnastomosisRecruitingNCT07504549Not applicable1 country
- A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsRecruitingNCT03093116Phase 1/219 countries
- Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)RecruitingNCT07284641Phase 21 country
- The Food Environment, Microbial Cysteine Metabolism, and Cancer DisparitiesRecruitingNCT07086833Not applicable1 country
- Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?RecruitingNCT06940596Not applicable1 country
- Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined.Enrolling by invitationNCT07546942Phase 1/21 country
- Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)RecruitingNCT063151791 country
- Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)Not yet recruitingNCT07537686Phase 2
- Peppermint Oil as a Treatment for Children With Bladder and Bowel DysfunctionEnrolling by invitationNCT05613153Not applicable1 country
- SCS Therapy for Patients With Bladder and Bowel Dysfunction After SCIRecruitingNCT07511244Not applicable1 country
- Study of Normal Intestinal Development and Disease in Premature and Term NeonatesRecruitingNCT066811291 country
- Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and EnteropahtyRecruitingNCT04528303Not applicable1 country
- Development of New Diagnostic Tools in Capsule EndoscopyRecruitingNCT061522891 country
- Noninvasive Spinal Cord Stimulation for Early SCIRecruitingNCT06587841Not applicable1 country
- Fortified Oral Rehydration Therapy for Pediatric DiarrheaRecruitingNCT06137014Phase 1/21 country
- Long-term Health Outcomes of Screen Detected and Potential Celiac Disease PatientsNot yet recruitingNCT073661511 country
- Capsule Endomicroscopy for Visualization of the Small Intestine in EED Population in PakistanEnrolling by invitationNCT04275167Not applicable1 country
- Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma PatientsRecruitingNCT049378681 country
- Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.RecruitingNCT05835973Not applicable1 country
- A Study to Evaluate Safety and Efficacy of PBK_M2502Not yet recruitingNCT07114406Phase 31 country
- Effect of Acupuncture on Mild to Moderate Active Crohn's DiseaseRecruitingNCT04187820Not applicable1 country
- DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne grouP PracticeNot yet recruitingNCT06178302
- Enteral Feeding of Fibre to Improve MicrobiotaRecruitingNCT06288464Not applicable1 country
- Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic ColectomyRecruitingNCT05224089Phase 41 country
- Transcutaneous Spinal Cord Stimulation Home StudyRecruitingNCT06838637Not applicable1 country
- InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's DiseaseRecruitingNCT06059989Phase 31 country
- Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCDRecruitingNCT063111101 country
- Effect of Pelvic Rehabilitation After Low Anterior Resection for Cancer Rectum. - A Randomised Controlled TrialNot yet recruitingNCT06524362Not applicable1 country
- SGM-101 in Colorectal Brain Metastases.RecruitingNCT04755920Phase 21 country
- Bladder and Bowel Dysfunction in ChildrenRecruitingNCT05318365Not applicable1 country
- Uronephrological Complications Risk Factors in Spinal DysraphismRecruitingNCT057184401 country
- Risk Factors for Bowel Dysfunction at Preschool and Early Childhood Age in Children With Hirschsprung DiseaseRecruitingNCT056558451 country
- Mental Stress and Bowel Preparation QualityRecruitingNCT060073131 country
- A Study to Evaluate Safety and Efficacy of PBK_M2101RecruitingNCT05923918Phase 31 country
- Spanish Series of Patients Treated With the Radionuclide Lutetium177RecruitingNCT049492821 country